Documentation Centre

 

 

  of 1494 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72:330-343 November 12, 2018 Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72:330-343 Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE Key Publications
Refining lipoprotein(a) associated cardiovascular risk in women. J Am Coll Cardiol. 2018;72:297-299 November 09, 2018 Refining lipoprotein(a) associated cardiovascular risk in women. J Am Coll Cardiol. 2018;72:297-299 Rosenson RS, Marcovina SM Key Publications
Lipoprotein(a) and cardiovascular risk prediction among women. J Am Coll Cardiol. 2018;72:287-296 November 08, 2018 Lipoprotein(a) and cardiovascular risk prediction among women. J Am Coll Cardiol. 2018;72:287-296 Cook NR, Mora S, Ridker PM Key Publications
Low-grade inflammation modifies cardiovascular risk even at very low LDL-C levels: Are we aiming for a dual target concept? Circulation. 2018;138:150-153 November 07, 2018 Low-grade inflammation modifies cardiovascular risk even at very low LDL-C levels: Are we aiming for a dual target concept? Circulation. 2018;138:150-153 Koenig W Key Publications
A Mediterranean-style eating pattern with lean, unprocessed red meat has cardiometabolic benefits for adults who are overweight or obese in a randomized, crossover, controlled feeding trial. Am J Clin Nutr. 2018;108:33-40 November 07, 2018 A Mediterranean-style eating pattern with lean, unprocessed red meat has cardiometabolic benefits for adults who are overweight or obese in a randomized, crossover, controlled feeding trial. Am J Clin Nutr. 2018;108:33-40 O'Connor LE, Paddon-Jones D, Wright AJ, Campbell WW Key Publications
Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138:141-149 November 06, 2018 Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation. 2018;138:141-149 Pradhan AD, Aday AW, Rose LM, Ridker PM Key Publications
Inflammatory and cholesterol risk in the FOURIER trial. Circulation. 2018;138:131-140 November 06, 2018 Inflammatory and cholesterol risk in the FOURIER trial. Circulation. 2018;138:131-140 Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, Lira Pineda A, Honarpour N, Wang H, Murphy SA, Keech A, Pedersen TR, Sabatine MS Key Publications
Low-density lipoprotein triglycerides: widening the atherogenic landscape in CVD risk assessment. J Am Coll Cardiol. 2018;72:170-172 October 26, 2018 Low-density lipoprotein triglycerides: widening the atherogenic landscape in CVD risk assessment. J Am Coll Cardiol. 2018;72:170-172 Miller M Key Publications
Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J Am Coll Cardiol. 2018;72:156-169 October 25, 2018 Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J Am Coll Cardiol. 2018;72:156-169 Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC Key Publications
Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding. J Lipid Res. 2018;59:1266-1275 October 25, 2018 Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding. J Lipid Res. 2018;59:1266-1275 Sniderman AD, Couture P, Martin SS, DeGraaf J, Lawler PR, Cromwell WC, Wilkins JT, Thanassoulis G Key Publications

  of 1494 Next page

Go to page: of